Bionano Genomics files updated legal opinion to increase ATM shares capacity to 149M

Bionano Genomics, Inc.

Updated legal opinion from Cooley LLP covers up to 149M shares under ATM sales agreement with Cowen.
Prior opinion covered 49M shares; new opinion triples authorized shares for at-the-market offerings.
Update required to maintain ATM program access under terms of $80M senior secured convertible notes issued in October 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.